Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

17.40 +0.67 (+4.00%)

Streaming Delayed Price Updated: 10:01 AM EDT, Sep 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	200,713
Open	16.73
Bid (Size)	17.33 (200)
Ask (Size)	17.47 (100)
Prev. Close	16.73
Today's Range	16.37 - 17.74
52wk Range	8.800 - 32.71
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

Today 9:32 EDT

From Bernstein Liebhard LLP

Via GlobeNewswire

Did You Lose Money Investing in Beta Bionics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against BBNX

September 14, 2026

San Diego, California--(Newsfile Corp. - September 14, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class...

Via Newsfile

Performance

YTD	-40.5%	-40.5%
1 Month	-0.9%	-0.9%
3 Month	+21.0%	+21.0%
6 Month	+60.1%	+60.1%
1 Year	-31.3%	-31.3%

More News

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

September 14, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

September 14, 2026

From Senseonics Holdings, Inc.

Via GlobeNewswire

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) Who Suffered Losses to Contact the Firm Before November 3, 2026

September 11, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Deadline Approaching: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

September 11, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 3, 2026

September 11, 2026

Via NewMediaWire

Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 3, 2026 - BBNX

September 11, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm Before Lead Plaintiff Deadline on November 3, 2026

September 10, 2026

Via NewMediaWire

Deadline Soon: Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

September 10, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

September 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline - Contact the Firm Before November 3, 2026

September 10, 2026

Via NewMediaWire

Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to a Securities Class Action Deadline on November 3, 2026

September 09, 2026

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Contact the Firm to Learn About Their Legal Rights

September 09, 2026

Via NewMediaWire

Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX

September 09, 2026

From SkyMedia, LLC

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX

September 09, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

BBNX Class Action Notice: Beta Bionics Sued for Securities Fraud After Allegedly Misleading Investors about the Safety of its Medical Device – Investors Urged to Contact BFA Law

September 09, 2026

From Bleichmar Fonti & Auld LLP

Via Business Wire

Law Offices of Frank R. Cruz Encourages Beta Bionics, Inc. (BBNX) Shareholders To Inquire About Securities Fraud Class Action

September 09, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Beta Bionics, Inc. (BBNX) Shareholders To Inquire About Securities Fraud Class Action

September 09, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Law Offices of Howard G. Smith Encourages Beta Bionics, Inc. (BBNX) Shareholders To Inquire About Securities Fraud Class Action

September 09, 2026

From Law Offices of Howard G. Smith

Via Business Wire

BBNX INVESTOR ALERT: Securities Class Action Filed Against Beta Bionics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

September 08, 2026

From Kirby McInerney LLP

Via Business Wire

BBNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026

September 08, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

BETA BIONICS, INC. (BBNX) INVESTOR ALERT Investors With Large Losses in Beta Bionics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

September 08, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

September 08, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Rosen Law Firm Urges Beta Bionics, Inc. (NASDAQ: BBNX) Stockholders to Contact the Firm for Information About Their Rights

September 08, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Frequently Asked Questions

Is Beta Bionics, Inc. - Common Stock publicly traded?

Yes, Beta Bionics, Inc. - Common Stock is publicly traded.

What exchange does Beta Bionics, Inc. - Common Stock trade on?

Beta Bionics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Beta Bionics, Inc. - Common Stock?

The ticker symbol for Beta Bionics, Inc. - Common Stock is BBNX on the Nasdaq Stock Market

What is the current price of Beta Bionics, Inc. - Common Stock?

The current price of Beta Bionics, Inc. - Common Stock is 17.40

When was Beta Bionics, Inc. - Common Stock last traded?

The last trade of Beta Bionics, Inc. - Common Stock was at 09/15/26 10:01 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.